These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6801103)

  • 1. Glycosaminoglycan in the skin and urine of a Hunter syndrome patient with a specific skin lesion.
    Nakamura T; Nishida K; Matsuda K; Kitano Y; Sano S; Yutaka T
    J Dermatol; 1981 Dec; 8(6):447-53. PubMed ID: 6801103
    [No Abstract]   [Full Text] [Related]  

  • 2. The Hurler and Hunter syndromes.
    Dorfman A; Matalon R
    Am J Med; 1969 Nov; 47(5):691-707. PubMed ID: 4243120
    [No Abstract]   [Full Text] [Related]  

  • 3. Mucopolysaccharidosis II (Hunter disease) with corneal opacities. Report on two patients at the extremes of a wide clinical spectrum.
    Spranger J; Cantz M; Gehler J; Liebaers I; Theiss W
    Eur J Pediatr; 1978 Aug; 129(1):11-6. PubMed ID: 150330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow transplantation in Hunter syndrome: a preliminary report.
    Warkentin PI; Dixon MS; Schafer I; Strandjord SE; Coccia PF
    Birth Defects Orig Artic Ser; 1986; 22(1):31-9. PubMed ID: 3083885
    [No Abstract]   [Full Text] [Related]  

  • 5. Acidic glycosaminoglycans and gangliosides in the brains from four patients with genetic mucopolysaccharidosis.
    Ikeno T; Minami R; Tsugawa S; Nakao T
    Tohoku J Exp Med; 1982 Jul; 137(3):253-60. PubMed ID: 6810503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hurler's, Hunter's and Morquio's syndromes. A biochemical study in the light of current views of the underlying defects.
    Dean MF; Muir H; Ewins RJ
    Biochem J; 1971 Aug; 123(5):883-94. PubMed ID: 4256532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased breakdown of glycosaminoglycans and appearance of corrective enzyme after skin transplants in Hunter syndrome.
    Dean MF; Muir H; Benson PF; Button LR; Batchelor JR; Bewick M
    Nature; 1975 Oct; 257(5527):609-12. PubMed ID: 126383
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone marrow transplantation in Hunter syndrome (mucopolysaccharidosis type II): two-year follow-up of the first Italian patient and review of the literature.
    Coppa GV; Gabrielli O; Zampini L; Pierani P; Giorgi PL; Jezequel AM; Orlandi F; Miniero R; Busca A; De Luca T
    Pediatr Med Chir; 1995; 17(3):227-35. PubMed ID: 7567644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative structural studies of urinary glycosaminoglycans in the Hurler and Hunter syndromes.
    Ramage P; Cunningham WL
    Biochim Biophys Acta; 1975 Dec; 411(2):325-33. PubMed ID: 127616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of dermatan sulfate and heparan sulfate in the urine of a patient with the Hunter syndrome.
    Kimura A; Hayashi S; Tsurumi K
    Tohoku J Exp Med; 1980 Jul; 131(3):227-39. PubMed ID: 6447930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The defect in Hurler and Hunter syndromes. II. Deficiency of specific factors involved in mucopolysaccharide degradation.
    Fratantoni JC; Hall CW; Neufeld EF
    Proc Natl Acad Sci U S A; 1969 Sep; 64(1):360-6. PubMed ID: 4244031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucopolysaccharidosis type II (Hunter's syndrome) in Taiwan.
    Su PH; Hwu WL; Chiang SC; Chiu PC; Lin SJ; Shu SG; Wang TR
    J Formos Med Assoc; 1998 Mar; 97(3):186-90. PubMed ID: 9549269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucopolysaccharidosis types IH, IS, II, and IIIA: glycosaminoglycans and lipids of isolated brain cells and other fractions from autopsied tissues.
    Constantopoulos G; Iqbal K; Dekaban AS
    J Neurochem; 1980 Jun; 34(6):1399-411. PubMed ID: 6770045
    [No Abstract]   [Full Text] [Related]  

  • 14. Mucopolysaccharidoses type II: enzymatic activity and quantitative and qualitative studies of urinary glycosaminoglycans in five patients.
    Gallegos-Arreola MP; González-Noriega A; Zúñiga-González GM; Flores-Martínez SE; Morán Moguel MC; Figuera LE; Sánchez-Corona J
    Arch Med Res; 1997; 28(1):91-4. PubMed ID: 9078594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hunter-Hurler syndrome. A prototype for the study of storage disease.
    Julius R; Aylsworth A; Rennert O
    J Fla Med Assoc; 1970 Sep; 57(9):23-5. PubMed ID: 4247390
    [No Abstract]   [Full Text] [Related]  

  • 16. Hurler and Hunter syndromes: mutual correction of the defect in cultured fibroblasts.
    Fratantoni JC; Hall CW; Neufeld EF
    Science; 1968 Nov; 162(3853):570-2. PubMed ID: 4236721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What syndrome is this? Hunter Syndrome.
    Lonergan CL; Payne AR; Wilson WG; Patterson JW; English JC
    Pediatr Dermatol; 2004; 21(6):679-81. PubMed ID: 15575857
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies in the Hunter-Hurler's syndrome.
    Dekaban A; Zelson J
    Trans Am Neurol Assoc; 1968; 93():75-8. PubMed ID: 4237227
    [No Abstract]   [Full Text] [Related]  

  • 19. First experience of enzyme replacement therapy with idursulfase in Spanish patients with Hunter syndrome under 5 years of age: case observations from the Hunter Outcome Survey (HOS).
    Alcalde-Martín C; Muro-Tudelilla JM; Cancho-Candela R; Gutiérrez-Solana LG; Pintos-Morell G; Martí-Herrero M; Munguira-Aguado P; Galán-Gómez E
    Eur J Med Genet; 2010; 53(6):371-7. PubMed ID: 20709629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild form of the Hunter syndrome, indentity of the biochemical defect with the severe type.
    Wiesmann UN; Rampini S
    Helv Paediatr Acta; 1974 Apr; 29(1):73-8. PubMed ID: 4275601
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.